Comments on: Entera Bio Phase 2 Data Supporting EB613’s (Oral PTH(1-34)) Anabolic Effect on Postmenopausal Women with Osteoporosis at High Risk for Fracture Selected for Plenary Poster Session Presentation at the ASBMR 2026 Annual Meeting

Comments on: Entera Bio Phase 2 Data Supporting EB613’s (Oral PTH(1-34)) Anabolic Effect on Postmenopausal Women with Osteoporosis at High Risk for Fracture Selected for Plenary Poster Session Presentation at the ASBMR 2026 Annual Meeting https://enterabio.com/news/entera-bio-phase-2-data-supporting-eb613s-oral-pth1-34-anabolic-effect-on-postmenopausal-women-with-osteoporosis-at-high-risk-for-fracture-selected-for-plenary-poster-session-presentation/ Global Leader in Oral Delivery of Therapeutic Proteins Tue, 04 Aug 2026 13:38:15 +0000 hourly 1 https://wordpress.org/?v=7.0.2